ArrayExpress Uploader04296DU-145noneDU-145noneDU-145noneDU-145converted to docetaxel-resistant cellsDU-145converted to docetaxel-resistant cellsDU-145converted to docetaxel-resistant cellsPC3nonePC3nonePC3nonePC3converted to docetaxel-resistant cellsPC3converted to docetaxel-resistant cellsPC3converted to docetaxel-resistant cellsarrayexpress_sid4Docetaxel-based chemotherapy is the standard first-line therapy in metastatic castration-resistant prostate cancer. However, most...22027694E-GEOD-33455/profile/8773/arrayexpressuploader212cancercellgenomelineprostateprostate cancerDec.12, 2014Falseexpression-data-from-docetaxel-resistant-prostateE-GEOD-33455_A-AFFY-44Expression data from docetaxel-resistant prostate cancer cell linesSep.16, 2014Docetaxel-based chemotherapy is the standard first-line therapy in metastatic castration-resistant prostate cancer. However, most patients eventually develop resistance to this treatment. The aim of the study was to identify key molecular genes and networks associated with docetaxel resistance in 2 models of docetaxel-resistant castration-resistant prostate cancer cell lines. DU-145 and PC-3 cells were converted to docetaxel-resistant cells, DU-145R and PC-3R, respectively. Whole-genome arrays were used to compare global gene expression between these 4 cell lines. Arrays were performed by triplicate for each cell line.http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-33455humanhttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-33455/samples/